Search - tctmd.com

Displaying 461 - 480 of 749

Sort: Relevancy | Date

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Industry News

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

October 30, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Presenter: Gregg Stone

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Daily News

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Caitlin E. Cox

October 25, 2013

News Daily News

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Caitlin E. Cox

October 25, 2013

News Industry News

Transcatheter Technologies Announces Successful Human Implantation of Its Repositionable Trinity Transapical Aortic Valve

October 24, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Industry News

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

October 22, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

News Daily News

High Long-term Survival Seen After TEVAR for Acute Dissection

Leah Lawrence

October 11, 2013

News Industry News

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

October 11, 2013

Advertisement

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

MiStent SES Shown to be Unique in Clinical Setting

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Transcatheter Technologies Announces Successful Human Implantation of Its Repositionable Trinity Transapical Aortic Valve

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Creganna-Tactx Medical to Showcase Expertise in Emerging Medical Therapies at TCT 2013

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

High Long-term Survival Seen After TEVAR for Acute Dissection

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content